Atconate 150mg Tablet (1s)

Product Overview

Atconate 150mg Tablets by Atco are a prescription medication used to treat osteoporosis in postmenopausal women. Osteoporosis is a condition that weakens bones, making them fragile and more likely to break. These tablets work by slowing down the process of bone loss and increasing bone mass, reducing the risk of fractures.

Key Benefits

Helps prevent bone fractures and improve bone density

- Easy-to-use tablet form for convenience

- Once-weekly dosing for ease of use

- Clinically proven to reduce the risk of fractures

- Can be taken with or without food

How It Works

Atconate 150mg Tablets contain the active ingredient Risedronate, which belongs to a class of medications called bisphosphonates. Risedronate works by slowing down the breakdown of bone cells, allowing the bones to rebuild and strengthen. This helps to increase bone density and reduce the risk of fractures.

Storage Instructions

Store Atconate 150mg Tablets at room temperature away from moisture and heat. Keep the tablets in their original packaging and out of reach of children.

Directions for Use

1. Take one Atconate 150mg Tablet once a week, preferably on the same day each week.

2. Swallow the tablet whole with a full glass of water.

3. Do not crush, chew, or suck on the tablet.

4. Do not lie down for at least 30 minutes after taking the tablet.

5. Follow your doctor's instructions carefully for the best results.

Precautions

Do not take Atconate 150mg Tablets if you have trouble swallowing, low blood calcium levels, or certain other medical conditions.

- Inform your doctor if you experience severe bone, joint, or muscle pain while taking this medication.

- Avoid taking any other medications, vitamins, or supplements within 30 minutes of taking Atconate 150mg Tablets.

Manufacturer Information

Atconate 150mg Tablets are manufactured by Atco Pharmaceuticals. Atco is a trusted pharmaceutical company known for producing high-quality medications that meet stringent safety and efficacy standards.